131 I-Anti CD20 Radioimmunotherapy of Relapsed or Refractory Non-Hodgkins Lymphoma: A Phase II Clinical Trial of a Nonmyeloblative Dose Regimen of Chimeric Rituximab Radiolabeled in a Hospital

J Turner, A.A. Martindale, J. Boucek, P.G. Claringbold, M.F. Leahy

    Research output: Contribution to journalArticle

    40 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)513-524
    JournalCancer Biotherapy and Radiopharmaceuticals
    Volume18
    Issue number4
    Publication statusPublished - 2003

    Cite this